Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
T. Rowe Price
TROW
$24.7B
| $1.5M | ﹤0.01% |
13,202
+1,867
| +16% | +$237K |
|
527
iShares Core MSCI EAFE ETF
IEFA
$194B
| $1.5M | ﹤0.01% |
25,401
-479
| -2% | -$30.7K |
|
528
iShares S&P 100 ETF
OEF
$20.6B
| $1.49M | ﹤0.01% |
8,632
+1,555
| +22% | +$291K |
|
529
Box
BOX
$4.45B
| $1.49M | ﹤0.01% |
+59,060
| New | +$1.65M |
|
530
MiMedx Group
MDXG
$618M
| $1.49M | ﹤0.01% |
428,041
+55,350
| +15% | +$217K |
|
531
Tenable Holdings
TENB
$3.98B
| $1.45M | ﹤0.01% |
+31,882
| New | +$1.64M |
|
532
Vanguard Energy ETF
VDE
$9.76B
| $1.43M | ﹤0.01% |
14,360
+2,002
| +16% | +$224K |
|
533
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $1.36M | ﹤0.01% |
21,472
+2,012
| +10% | +$140K |
|
|
FLGE
534
DELISTED
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
| $1.34M | ﹤0.01% |
1,662
-112
| -6% | -$90.6K |
|
535
PDF Solutions
PDFS
$2.09B
| $1.34M | ﹤0.01% |
+62,150
| New | +$1.44M |
|
536
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $1.31M | ﹤0.01% |
30,431
+400
| +1% | +$19.1K |
|
537
Teleflex
TFX
$6.2B
| $1.31M | ﹤0.01% |
5,320
-151
| -3% | -$44K |
|
538
Myriad Genetics
MYGN
$307M
| $1.31M | ﹤0.01% |
71,857
+328
| +0.5% | +$6.81K |
|
539
Fidelity National Information Services
FIS
$22.3B
| $1.29M | ﹤0.01% |
14,100
+167
| +1% | +$16.6K |
|
540
CVB Financial
CVBF
$4.06B
| $1.28M | ﹤0.01% |
51,786
+348
| +0.7% | +$8.32K |
|
541
Trane Technologies
TT
$105B
| $1.26M | ﹤0.01% |
9,743
-830
| -8% | -$115K |
|
542
OraSure Technologies
OSUR
$287M
| $1.26M | ﹤0.01% |
464,602
+104,731
| +29% | +$521K |
|
543
GE Aerospace
GE
$397B
| $1.26M | ﹤0.01% |
31,704
+1,411
| +5% | +$68.4K |
|
544
Hackett Group
HCKT
$274M
| $1.26M | ﹤0.01% |
+66,331
| New | +$1.43M |
|
545
A10 Networks
ATEN
$2.19B
| $1.25M | ﹤0.01% |
+86,795
| New | +$1.26M |
|
546
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.2B
| $1.23M | ﹤0.01% |
19,565
+35
| +0.2% | +$2.39K |
|
547
Berkshire Hathaway Class A
BRK.A
$1.11T
| $1.23M | ﹤0.01% |
+3
| New | +$1.41M |
|
548
iShares MSCI Spain ETF
EWP
$2.15B
| $1.23M | ﹤0.01% |
52,567
-8,041
| -13% | -$200K |
|
549
iShares Global Financials ETF
IXG
$688M
| $1.22M | ﹤0.01% |
18,519
-248
| -1% | -$17.9K |
|
550
Pacira BioSciences
PCRX
$1B
| $1.21M | ﹤0.01% |
20,804
+85
| +0.4% | +$5.57K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.